{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:02:13Z","timestamp":1776258133932,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12185-025-04137-3","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:24:24Z","timestamp":1766424264000},"page":"600-606","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes of allogeneic hematopoietic stem cell transplantation for acquired pure red cell aplasia"],"prefix":"10.1007","volume":"123","author":[{"given":"Yuma","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8176-4760","authenticated-orcid":false,"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Kanaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Matsue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Onizuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seitaro","family":"Terakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yoshihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuto","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"4137_CR1","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1182\/blood-2016-05-717140","volume":"128","author":"RT Means Jr","year":"2016","unstructured":"Means RT Jr. Pure red cell aplasia. Blood. 2016;128:2504\u20139.","journal-title":"Blood"},{"key":"4137_CR2","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.1182\/bloodadvances.2021006486","volume":"6","author":"H Nakazawa","year":"2022","unstructured":"Nakazawa H, Sakai K, Ohta A, Fujishima N, Matsuda A, Hosokawa K, et al. Incidence of acquired pure red cell aplasia: a nationwide epidemiologic analysis with 2 registry databases in Japan. Blood Adv. 2022;6:6282\u201390.","journal-title":"Blood Adv"},{"key":"4137_CR3","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bjh.13376","volume":"169","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa M, Sawada K, Fujishima N, Teramura M, Bessho M, Dan K, et al. Long-term outcome of patients with acquired chronic pure red cell aplasia (PRCA) following immunosuppressive therapy: a final report of the nationwide cohort study in 2004\/2006 by the Japan PRCA collaborative study group. Br J Haematol. 2015;169:879\u201386.","journal-title":"Br J Haematol"},{"key":"4137_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ajh.10421","volume":"74","author":"S-B Tseng","year":"2003","unstructured":"Tseng S-B, Lin S-F, Chang C-S, Liu T-C, Hsiao H-H, Liu Y-C, et al. Successful treatment of acquired pure red cell aplasia (PRCA) by allogeneic peripheral blood stem cell transplantation. Am J Hematol. 2003;74:273\u20135.","journal-title":"Am J Hematol"},{"key":"4137_CR5","doi-asserted-by":"publisher","first-page":"E294","DOI":"10.1002\/ajh.25609","volume":"94","author":"C Halkes","year":"2019","unstructured":"Halkes C, de Wreede LC, Knol C, Simand C, Aljurf M, Tbakhi A, et al. Allogeneic stem cell transplantation for acquired pure red cell aplasia. Am J Hematol. 2019;94:E294\u20136.","journal-title":"Am J Hematol"},{"key":"4137_CR6","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41409-020-01126-4","volume":"56","author":"M Khan","year":"2021","unstructured":"Khan M, Iftikhar R, Ghafoor T, Hussain F, Chaudhry QUN, Mahmood SK, et al. Allogeneic hematopoietic stem cell transplant in rare hematologic disorders: a single center experience from Pakistan. Bone Marrow Transplant. 2021;56:863\u201372.","journal-title":"Bone Marrow Transplant"},{"key":"4137_CR7","unstructured":"Ishida F, Nakazawa H, Harigae H, et al. A clinical reference and guide on pure red cell aplasia: Revised edition 2022. https:\/\/zoketsushogaihan.umin.jp\/file\/2022\/pure_red_cell_aplasia.pdf. Accessed 8 Nov 2025."},{"key":"4137_CR8","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 2013;48:452\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"4137_CR9","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/sj.bmt.1701785","volume":"23","author":"BU M\u00fcller","year":"1999","unstructured":"M\u00fcller BU, Tichelli A, Passweg JR, Nissen C, Wodnar-Filipowicz A, Gratwohl A. Successful treatment of refractory acquired pure red cell aplasia (PRCA) by allogeneic bone marrow transplantation. Bone Marrow Transplant. 1999;23:1205\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"4137_CR10","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/sj.bmt.1704419","volume":"33","author":"M Musso","year":"2004","unstructured":"Musso M, Porretto F, Crescimanno A, Polizzi V, Scalone R. Donor lymphocyte infusions for refractory pure red cell aplasia relapsing after both autologous and nonmyeloablative allogeneic peripheral stem cell transplantation. Bone Marrow Transplant. 2004;33:769\u201371.","journal-title":"Bone Marrow Transplant"},{"key":"4137_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/sj.bmt.1704993","volume":"36","author":"G Kochethu","year":"2005","unstructured":"Kochethu G, Baden HS, Jaworska E, Chang J, Chopra R. Reduced intensity conditioning bone marrow transplantation for pure red cell aplasia: successful outcome but difficult post transplant course. Bone Marrow Transplant. 2005;36:81\u20132.","journal-title":"Bone Marrow Transplant"},{"key":"4137_CR12","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.hemonc.2017.09.001","volume":"12","author":"A Simkins","year":"2019","unstructured":"Simkins A, Maiti A, Short NJ, Jain N, Popat U, Patel KP, et al. Acquired amegakaryocytic thrombocytopenia and red cell aplasia in a patient with thymoma progressing to aplastic anemia successfully treated with allogenic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2019;12:115\u20138.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"4137_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s12185-016-1960-z","volume":"103","author":"T Mori","year":"2016","unstructured":"Mori T, Koh H, Onishi Y, Kako S, Onizuka M, Kanamori H, et al. Impact of cyclophosphamide dose of conditioning on the outcome of allogeneic hematopoietic stem cell transplantation for aplastic anemia from human leukocyte antigen-identical sibling. Int J Hematol. 2016;103:461\u20138.","journal-title":"Int J Hematol"},{"key":"4137_CR14","doi-asserted-by":"publisher","first-page":"976","DOI":"10.3324\/haematol.2009.018267","volume":"95","author":"A Bacigalupo","year":"2010","unstructured":"Bacigalupo A, Socie\u2019 G, Lanino E, Prete A, Locatelli F, Locasciulli A, et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica. 2010;95:976\u201382.","journal-title":"Haematologica"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04137-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04137-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:56:44Z","timestamp":1776254204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04137-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4137"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04137-3","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}